GHK-Cu doesn't affect androgens (unlike finasteride), making it suitable for women where DHT-blocking drugs aren't appropriate
IGF1, Insulin-like growth factor 1
[Anti-candidal activity of clinical Pseudomonas aeruginosa strains and in vitro inhibition of Candida biofilm formation]
Through coordinated GLP-1R and GIPR activation, tirzepatide enhances glucose-dependent insulin secretion, improves glycemic control, contributes to lipid homeostasis, and reduces appetite and food intake, supporting its clinical use in obesity and type 2 diabetes [13]
Additionally, we have updated the product volume from 90 to 60 capsules per bottle, new price also reflects this change
Dutasteride blocks both Type 1 and Type 2, reducing DHT by approximately 98 percent [4]